William B. Hughson
First SEC filing: Aug. 31, 2012 · Latest: Aug. 31, 2012
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 29, 2012 | CVSA | A | 21,998 | · | · | 21,998 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 29, 2012 | CVSA | A | 5,377 | · | · | 5,377 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 29, 2012 | CVSA | A | 6,050 | · | · | 7,050 Direct | +605.00% | Acquired | (price as of 2026-10-02) |
| Aug. 28, 2012 | CVSA | F | 526 | $19.12 | $10,057 | 2,143 Direct | -19.71% | Disposed | 556.3% (price as of 2026-10-02) |
| Aug. 28, 2012 | CVSA | A | 1,669 | · | · | 2,669 Direct | +166.90% | Acquired | (price as of 2026-10-02) |
| Aug. 24, 2011 | CVSA | A | 14,637 | · | · | 14,637 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 24, 2011 | CVSA | A | 2,388 | · | · | 2,388 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 27, 2010 | CVSA | A | 2,621 | · | · | 2,621 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 27, 2010 | CVSA | A | 13,754 | · | · | 13,754 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 25, 2010 | CVSA | P | 100 | $38.35 | $3,835 | 100 Direct | · | Acquired | 227.2% (price as of 2026-10-02) |
| Aug. 25, 2010 | CVSA | P | 900 | $38.35 | $34,515 | 1,000 Direct | +900.00% | Acquired | 227.2% (price as of 2026-10-02) |
| Nov. 10, 2009 | CVSA | A | 7,025 | · | · | 7,025 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 29, 2012 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock | $18.60 | Aug. 29, 2022 | 21,998 | Acquired |
| Aug. 29, 2012 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock | $18.60 | Aug. 29, 2022 | 5,377 | Acquired |
| Aug. 24, 2011 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock | $41.87 | Aug. 24, 2021 | 14,637 | Acquired |
| Aug. 24, 2011 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock | $41.87 | Aug. 24, 2021 | 2,388 | Acquired |
| Aug. 27, 2010 | CVSA | Incentive Stock Option (right to buy) | Common Stock | $38.71 | Aug. 27, 2020 | 2,621 | Acquired |
| Aug. 27, 2010 | CVSA | Non-Qualified Stock Option (right to buy) | Common Stock | $38.71 | Aug. 27, 2020 | 13,754 | Acquired |
| Nov. 10, 2009 | CVSA | Incentive Stock Option (right to buy) | Common Stock | $54.15 | Nov. 10, 2019 | 7,025 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2012 | $413,882 | · | · | · | $91,658 | · | $25,225 | $962,333 |
| 2011 | $383,221 | · | · | · | $239,630 | · | $339,531 | $1,351,853 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.